Also trades as: 0QCV.IL (IOB) · $vol 4M · 0QCV.L (LSE) · $vol 4M · 4AB.DE (XETRA) · $vol 0M · ABBV.TO (TSX) · $vol 0M · ABBV.BA (BUE) · $vol 0M · 4AB.DU (DUS) · $vol 0M
ABBV NYSE
AbbVie Inc.
1W: +0.4%
1M: +8.6%
3M: +11.1%
YTD: +25.7%
1Y: +25.4%
3Y: +112.0%
5Y: +205.9%
$286.35
-0.04 (-0.01%)
After Hours: $287.61 (+1.25, +0.44%)
Weekly Expected Move ±3.1%
$268
$277
$286
$295
$304
Credit Risk of going bust: lower than 84% of companies Debt: 12.3% of company value Bonds: $2.06B held by 633 funds, 61 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.59 (down 99.1%), AbbVie Inc. would be worth roughly what it owes.
Total debt $70.82B against a stock market value of $506.17B.
Distance to default 11.00 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $39.58B (short-term plus half of long-term), stock volatility 25.7%; Altman Z 2.71. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $2.59 (down 99.1%), AbbVie Inc. would be worth roughly what it owes.
Total debt $70.82B against a stock market value of $506.17B.
Distance to default 11.00 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $39.58B (short-term plus half of long-term), stock volatility 25.7%; Altman Z 2.71. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
2 bullish
0 neutral
0 bearish
Articles (24h)
2
Hourly Sentiment (24h)
0.30
Neutral
13 bullish
10 neutral
4 bearish
Articles (7d)
27
Daily Sentiment (7 Days)
Articles (100)
How Are LLY's Neuroscience and Immunology Drugs Poised Ahead of Q3?
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
AbbVie submits etentamig BLA for multiple myeloma
4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
Buy, Hold or Sell ABBV Stock? Key Tips Ahead of Q3 Earnings
What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
AbbVie Inc. $ABBV Shares Sold by Hilton Head Capital Partners LLC
Apollon Wealth Management LLC Purchases 22,722 Shares of AbbVie Inc. $ABBV
3,545 AbbVie Inc. $ABBV Shares Purchased by IRON Financial LLC
AbbVie Inc. $ABBV Stock Holdings Lessened by Citizens Financial Group Inc. RI
Billionaire Ken Griffin Is Buying This Dividend King That Wall Street Still Rates a Buy
Earnings Week Ahead: MSFT, GOOGL, AMZN, XOM, BA, VZ, and more
AbbVie Inc. $ABBV Stock: Evergreen Capital Management LLC Grows Stake
Catalyst watch: Fed meeting, earnings blitz, Oracle AI event, and a pure-play hockey stock
BMY vs. ABBV: Which Pharma/Biotech Stock Offers More Upside Potential?
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
AbbVie Inc. $ABBV Shares Sold by Cantor Fitzgerald Investment Advisors L.P.
6,790 AbbVie Inc. $ABBV Shares Sold by AMF Tjanstepension AB
What Higher Interest Rates Mean for Dividend Stocks Like AbbVie and Pfizer
Great News for AbbVie Stock Investors
AbbVie sees positive late-stage results for lutikizumab in hidradenitis suppurativa
AbbVie (ABBV) Is Considered a Good Investment by Brokers: Is That True?
AbbVie Inc. $ABBV Shares Newly Purchased by Capstone Capital Management Ltd
AbbVie Inc. $ABBV Shares Newly Purchased by Capstone Capital Management Ltd
AbbVie Inc. $ABBV Stock Sold by Axxcess Wealth Management LLC
AbbVie Inc. $ABBV Stock Sold by Axxcess Wealth Management LLC
AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors
AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue?
AbbVie Inc. $ABBV Position Boosted by Focused Alpha LLC
AbbVie vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
XLV touches a new high, hitting overbought territory
Kevin Warsh's Fed May Not Cut Rates Soon. That's Why This Dividend Stock Belongs in Your Portfolio.
Alvotech wins FDA nod for new manufacturing process for Humira biosimilar
Novem Group Sells 3,428 Shares of AbbVie Inc. $ABBV
Greg Jennings LLC Makes New Investment in AbbVie Inc. $ABBV
2 High-Flying Dividend Stocks to Buy and Hold for a Decade
Zacks Market Edge Highlights: Palantir Technologies, BP, Palo Alto Networks, Visa and AbbVie
AbbVie's Neuroscience Franchise: What to Expect Ahead of Q3 Results
AbbVie Inc. $ABBV Shares Sold by First Bank & Trust
1,939 AbbVie Inc. $ABBV Shares Acquired by IFP Advisors Inc
Warren Buffett's Bluntest Warning Yet -- and 3 Stocks Built to Survive It
Goldman's defensive stocks with quality-growth characteristics
Ken Griffin Increased His Position in This Dividend King by a Whopping 546% in Q2. Here's Why It's Still a Buy.
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys
AbbVie Inc. $ABBV Shares Sold by Banque Pictet & Cie SA
AbbVie Inc. $ABBV Stock: Aspiriant LLC Reduces Holdings
Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends
5 Stock Ideas for Your Short List
Nvidia-backed drug discovery firm Iambic climbs on trading debut
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie Inc. $ABBV Position Reduced by Cliftonlarsonallen Wealth Advisors LLC
Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?
Bet on These Healthcare ETFs to Benefit From the Aging US Population
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
AbbVie releases phase 3 induction therapy data on injectable Skyrizi for Crohn's
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie, Eli Lilly among mega-cap healthcare stocks with A+ profitability grades
AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts
Will Skyrizi & Rinvoq Drive AbbVie's Top-Line Growth in Q3?
AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends?
Hospital group files lawsuit to stop 340B rebate pilot again
AbbVie Inc. $ABBV Shares Sold by Bill Few Associates Inc.
Capital Planning LLC Sells 7,500 Shares of AbbVie Inc. $ABBV
Catalyst watch: Big bank earnings, CPI, and the Paris Auto Show
A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens
Cancer Stocks to Consider as Oncology Innovation Accelerates
Dividend Roundup: Starbucks, Pfizer, Micron, AbbVie, and more
AbbVie Inc. $ABBV Stock Sold by Bell Asset Management Ltd
GAMMA Investing LLC Purchases 7,058 Shares of AbbVie Inc. $ABBV
AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer
Nvidia-backed Iambic seeks a valuation exceeding $800M in U.S. IPO
UBS flags 56 stocks where growth and profitability may be underpriced
5 Stocks to Buy That Have Raised Their Dividends Every Year Since 2000
15 dividend stocks beating the S&P 500 as markets sit near record highs
2026 Takes a Promising Turn in the Fight Against Cancer as Five Advances Offer New Hope
Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?
3 of the Best Growth Stocks to Buy in October 2026
HSBC Thinks AbbVie Can Climb to $315. Here's the Bull Case in Plain English.
AbbVie's Epcoritamab Combo Shows PFS Benefit in Frontline DLBCL
Should You Buy AbbVie Stock Before Oct. 30?
Wall Street Analysts See AbbVie (ABBV) as a Buy: Should You Invest?
AbbVie flags $216M IPR&D and milestones expense for Q3
Why AbbVie (ABBV) Outpaced the Stock Market Today
Genmab, AbbVie data boosts Epkinly as first-line B-cell lymphoma treatment
Why I Think These Are the 2 Smartest Stocks to Buy With $5,000 in October
Park National Corp OH Sells 6,771 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Position Lowered by Eastern Bank
Regenxbio a new Outperform at Mizuho on potential of two pipeline drugs
FDA Expands Eli Lilly's Blood Cancer Drug Label in First-Line Setting
FDA approves additional U.S. manufacturing capacity for Simlandi, Alvotech’s biosimilar to Humira
AbbVie Inc. $ABBV Stock Position Lessened by MassMutual Private Wealth & Trust FSB
AbbVie Inc. $ABBV Stake Reduced by Violich Capital Management Inc.
AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot
AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.
How to Create a Million-Dollar Stock Portfolio
Eli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphoma
3 of the Best ETFs to Buy and Hold if a Recession Is Coming